Clinical Trial Update: Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the safety and efficacy of daptomycin for complicated skin and skin-structure infections. The study was terminated and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections
• Staphylococcal Skin Infections

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

Sponsor: Novartis | Conditions: Staphylococcal Skin Infections | Phase 4 | Status: TERMINATED | Results posted: 2010-12-23